Response to "Three drugs are unnecessary for treating paucibacillary leprosy-A critique of the WHO guidelines".

We read with interest the viewpoint by Lockwood and colleagues on the recent World Health Organization (WHO) guidelines recommending three drugs for treating paucibacillary (PB) leprosy. Out of the various other issues raised by the authors (namely, diagnostic tests, reactions, stigma, and disability), we would like to submit our perception only on the issue of addition of clofazimine to this recommended therapeutic regimen.